|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7684 USD | +1.05% |
|
+0.18% | -43.08% |
| 06-29 | Rani Therapeutics Holdings, Inc. Announces Appointment of Nicholas Maestas as Chief Financial Officer, Effective June 29, 2026 | CI |
| 06-29 | Rani Therapeutics Names Nicholas Maestas CFO | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 0.8844 | 1.49 | 2.2 |
| Spread/Res. | -13.12% | -48.43% | -65.07% |
| Spread/Supp. | +4.57% | +4.57% | +67.70% |
| Support | 0.7348 | 0.7348 | 0.4582 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RANI Stock
- Charts Rani Therapeutics Holdings, Inc.
Select your edition
All financial news and data tailored to specific country editions
